KA
IBB icon

Kovack Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Kovack Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$454K Buy
2,894
+41
+1% +$7.01K 0.02% 617
2025
Q4 		$482K Buy
2,853
+696
+32% +$113K 0.02% 605
2025
Q3 		$311K Sell
2,157
-13
-0.6% -$1.77K 0.03% 454
2025
Q2 		$275K Buy
2,170
+266
+14% +$32.7K 0.03% 492
2025
Q1 		$243K Sell
1,904
-156
-8% -$21.2K 0.03% 480
2024
Q4 		$272K Buy
2,060
+104
+5% +$14.6K 0.03% 475
2024
Q3 		$285K Sell
1,956
-130
-6% -$18.8K 0.03% 451
2024
Q2 		$286K Hold
2,086
– – 0.03% 430
2024
Q1 		$286K Buy
2,086
+1
+0% +$137 0.03% 363
2023
Q4 		$283K Sell
2,085
-294
-12% -$35.9K 0.03% 429
2023
Q3 		$291K Hold
2,379
– – 0.04% 401
2023
Q2 		$302K Sell
2,379
-485
-17% -$63K 0.04% 413
2023
Q1 		$370K Sell
2,864
-60
-2% -$7.85K 0.05% 361
2022
Q4 		$384K Sell
2,924
-211
-7% -$27.3K 0.06% 339
2022
Q3 		$367K Sell
3,135
-273
-8% -$33.9K 0.05% 360
2022
Q2 		$401K Sell
3,408
-683
-17% -$81.1K 0.05% 374
2022
Q1 		$533K Sell
4,091
-275
-6% -$35.8K 0.05% 373
2021
Q4 		$666K Buy
4,366
+1,114
+34% +$172K 0.06% 318
2021
Q3 		$526K Buy
3,252
+12
+0.4% +$2.02K 0.06% 370
2021
Q2 		$530K Sell
3,240
-740
-19% -$114K 0.06% 338
2021
Q1 		$599K Buy
3,980
+911
+30% +$145K 0.08% 276
2020
Q4 		$465K Buy
3,069
+334
+12% +$47.7K 0.07% 293
2020
Q3 		$370K Buy
2,735
+176
+7% +$23.9K 0.07% 289
2020
Q2 		$350K Buy
+2,559
New +$326K 0.07% 287
2020
Q1 		– Sell
-2,430
Closed -$293K – 509
2019
Q4 		$293K Sell
2,430
-1,243
-34% -$139K 0.05% 360
2019
Q3 		$365K Sell
3,673
-429
-10% -$44.9K 0.07% 285
2019
Q2 		$447K Sell
4,102
-507
-11% -$53.9K 0.1% 228
2019
Q1 		$515K Buy
4,609
+584
+15% +$64.1K 0.13% 194
2018
Q4 		$388K Sell
4,025
-170
-4% -$18K 0.11% 210
2018
Q3 		$512K Buy
4,195
+338
+9% +$39.8K 0.13% 195
2018
Q2 		$424K Sell
3,857
-636
-14% -$68K 0.12% 203
2018
Q1 		$480K Sell
4,493
-3,232
-42% -$358K 0.12% 197
2017
Q4 		$825K Buy
7,725
+1,725
+29% +$184K 0.21% 119
2017
Q3 		$667K Sell
6,000
-879
-13% -$93.9K 0.22% 113
2017
Q2 		$711K Buy
6,879
+3,621
+111% +$357K 0.22% 108
2017
Q1 		$319K Sell
3,258
-2,184
-40% -$209K 0.12% 182
2016
Q4 		$481K Sell
5,442
-3,006
-36% -$274K 0.23% 106
2016
Q3 		$815K Buy
8,448
+4,938
+141% +$470K 0.4% 62
2016
Q2 		$301K Hold
3,510
– – 0.16% 155
2016
Q1 		$305K Sell
3,510
-267
-7% -$23.9K 0.19% 131
2015
Q4 		$426K Buy
3,777
+1,713
+83% +$186K 0.28% 101
2015
Q3 		$209K Sell
2,064
-543
-21% -$65.1K 0.15% 170
2015
Q2 		$321K Buy
2,607
+855
+49% +$102K 0.23% 120
2015
Q1 		$201K Buy
+1,752
New +$193K 0.17% 155

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Kovack Advisors's IBB Position: Q1 2026 in Review

Kovack Advisors increased its iShares Biotechnology ETF (IBB) stake by 1.4% in Q1 2026, buying an estimated $7.01K and bringing the position to 2,894 shares worth $454K. The position accounts for 0.02% of the portfolio, ranked #617.

Kovack Advisors first reported a position in IBB in Q1 2015 and has held it in 44 quarters since. The position peaked at $825K in Q4 2017. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Kovack Advisors held 2,894 shares of iShares Biotechnology ETF worth $454K as of Q1 2026.
  • Kovack Advisors bought 41 iShares Biotechnology ETF shares in Q1 2026, an estimated $7.01K.
  • iShares Biotechnology ETF made up 0.02% of Kovack Advisors's portfolio in Q1 2026, its #617 holding.
  • Kovack Advisors first reported a position in iShares Biotechnology ETF in Q1 2015 and has held it in 44 quarters since.
  • Kovack Advisors's iShares Biotechnology ETF position peaked at $825K in Q4 2017.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Kovack Advisors's 13F filing for Q1 2026, filed 13 May 2026.